BioSpace News Archive

The global RNA and DNA extraction kit market is expected to post a CAGR of more than 7% during the period 2019-2023, according to the latest market research report by Technavio.

Americans may see groups like Antifa as student radicals who show up at street demonstrations to protest politically incorrect monuments but who mainly hang out in coffee shops near campus.

The fifth annual urgent care conference, hosted by the North East Regional Urgent Care Association, will bring together urgent care owners, administrators, and providers to hear about relevant industry topics and celebrate five years of the NERUCA Urgent Care Conference

A comprehensive home-based care program for Blue Shield of California members with five or more specific chronic illnesses has been widely embraced in its first 12 months.

Jamie M. Howder, FNP-BC was voted a “Top Aesthetic Nurse Practitioner” for the third straight year in the Aesthetic Everything® Awards.

China SXT Pharmaceuticals, Inc. (SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (“TCMPs”), announced today the launch of a strategic partnership with Future Science & Technology Park of Huangshan Hi-tech Zone and Huangshan Panjie Investment Co., Ltd.

Enleofen Bio announced the publication of promising data from a preclinical study of a novel therapy targeting a severe form of fatty liver disease.

Co-Diagnostics, Inc. announced it has entered into two sales agreements for mosquito abatement laboratory equipment and mosquito tests, and expects additional sales agreements before the end of the quarter.

Synlogic, Inc. announced a new clinical collaboration with Roche, to explore Synlogic’s Synthetic Biotic™ medicine, SYNB1891, a dual innate immune activator engineered to express a STING agonist, in combination with Roche’s PD-L1-blocking checkpoint inhibitor atezolizumab in patients with advanced solid tumors.

The WOA meeting was developed primarily for orthopedic and trauma surgeons and allied health professionals.